Surgery Partners (NASDAQ:SGRY) Sees Unusually-High Trading Volume – Here’s Why

Shares of Surgery Partners, Inc. (NASDAQ:SGRY) saw an uptick in trading volume on Wednesday. 6,326,966 shares changed hands during trading, an increase of 202% from the average daily volume of 2,098,303 shares. The stock last traded at $23.2250 and had previously closed at $23.13.

Key Surgery Partners News

Here are the key news stories impacting Surgery Partners this week:

• Positive Sentiment: The proposed cash acquisition provides a potential near-term exit price of $23.50 per share and is likely supporting SGRY’s valuation. Article: Wohl & Fruchter investigates proposed sale
• Neutral Sentiment: Several law firms announced investigations into whether the $23.50-per-share merger is fair to shareholders. These announcements raise the possibility of deal scrutiny or delay, but do not themselves indicate that the offer will change or that wrongdoing occurred. Article: BFA Law merger investigation Article: Monteverde merger investigation
• Negative Sentiment: TD Cowen cut its rating from “strong buy” to “hold,” removing a bullish analyst endorsement. Article: TD Cowen stock recommendations
• Negative Sentiment: KeyCorp lowered its earnings forecasts, projecting $0.07 per share for 2026 (previously $0.16) and a loss of $0.21 per share for 2027 (previously an expected profit of $0.13). The weaker outlook could weigh on sentiment, although the proposed sale is the more immediate focus. Article: Surgery Partners analyst estimates

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on SGRY. UBS Group cut shares of Surgery Partners from a “buy” rating to a “hold” rating and boosted their price objective for the stock from $21.00 to $23.50 in a research note on Wednesday, October 28th. TD Cowen lowered shares of Surgery Partners from a “strong-buy” rating to a “hold” rating in a research note on Saturday. Benchmark reiterated a “buy” rating on shares of Surgery Partners in a report on Tuesday, August 11th. Zacks Research downgraded shares of Surgery Partners from a “strong-buy” rating to a “hold” rating in a report on Monday, August 10th. Finally, Royal Bank Of Canada lowered shares of Surgery Partners from a “moderate buy” rating to a “hold” rating and set a $23.50 target price for the company. in a research report on Monday, October 26th. Three research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $20.14.

Surgery Partners Trading Up 0.1%

The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.78 and a current ratio of 1.95. The company has a 50-day simple moving average of $15.49 and a 200 day simple moving average of $14.72. The company has a market capitalization of $3.03 billion, a P/E ratio of -33.08 and a beta of 1.85.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings data on Monday, August 10th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of $0.06 by $0.04. The company had revenue of $848.90 million during the quarter, compared to analysts’ expectations of $830.03 million. Surgery Partners had a positive return on equity of 0.88% and a negative net margin of 2.63%. Surgery Partners’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.17 earnings per share. Sell-side analysts expect that Surgery Partners, Inc. will post 0.22 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Teresa DeLuca purchased 10,000 shares of Surgery Partners stock in a transaction on Tuesday, August 18th. The stock was purchased at an average cost of $14.35 per share, with a total value of $143,500.00. Following the acquisition, the director directly owned 66,843 shares in the company, valued at approximately $959,197.05. This trade represents a 17.59% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. 2.00% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Jupiter Topco LLC bought a new stake in Surgery Partners in the 2nd quarter valued at $233,220,000. Pentwater Capital Management LP acquired a new position in shares of Surgery Partners in the 2nd quarter valued at $195,384,000. BlackRock Inc. bought a new position in shares of Surgery Partners during the 2nd quarter worth about $104,857,000. Dimensional Fund Advisors LP lifted its holdings in shares of Surgery Partners by 7.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 5,296,411 shares of the company’s stock worth $63,131,000 after acquiring an additional 389,831 shares during the period. Finally, Hsbc Holdings PLC bought a new position in shares of Surgery Partners during the 2nd quarter worth about $48,912,000.

About Surgery Partners

Surgery Partners, Inc is a U.S.-based healthcare services company that operates and manages ambulatory surgery centers and surgical hospitals. The company works with physicians, health systems and other healthcare providers to deliver outpatient surgical care in facilities designed for same-day procedures.

Its facilities provide surgical services across specialties such as orthopedics, pain management, ophthalmology, gastroenterology, urology, gynecology and general surgery. Surgery Partners also supports its operations with clinical, administrative and revenue-cycle services intended to help physicians and facility partners manage patient care and practice operations.

Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners has expanded its platform through acquisitions, joint ventures and other partnerships.